Literature DB >> 22258349

Successful treatment of disseminated cryptococcal infection in a pediatric acute lymphoblastic leukemia patient during induction.

Jessica L Heath1, Dwight E Yin, Daniel S Wechsler, David A Turner.   

Abstract

Disseminated cryptococcal infection is rarely reported in the setting of pediatric acute leukemia, despite the immunocompromised state of these patients. However, when present, disseminated cryptococcal infection poses treatment challenges and is associated with significant morbidity and mortality. Treatment of invasive fungal disease in a child with acute leukemia requires a delicate balance between antifungal and antineoplastic therapy. This balance is particularly important early in the course of leukemia, as both the underlying disease and overwhelming infection can be life threatening. We describe the successful management of life-threatening disseminated cryptococcosis in a child with acute lymphoblastic leukemia during induction therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258349      PMCID: PMC4628791          DOI: 10.1097/MPH.0b013e318236c502

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  10 in total

1.  Cryptococcal meningitis during front-line chemotherapy for acute lymphoblastic leukemia.

Authors:  B Urbini; C Castellini; R Rondelli; A Prete; S Pierinelli; A Pession
Journal:  Haematologica       Date:  2000-10       Impact factor: 9.941

2.  Cryptococcal meningitis in a child with acute lymphoblastic leukemia.

Authors:  Annelies M C Mavinkurve-Groothuis; Jos P M Bokkerink; Paul E Verweij; Anjo J P Veerman; Peter M Hoogerbrugge
Journal:  Pediatr Infect Dis J       Date:  2003-06       Impact factor: 2.129

3.  Invasive fungal disease in patients treated for newly diagnosed acute leukemia.

Authors:  Sarah P Hammond; Francisco M Marty; Julie M Bryar; Daniel J DeAngelo; Lindsey R Baden
Journal:  Am J Hematol       Date:  2010-09       Impact factor: 10.047

4.  Sudden death due to disseminated cryptococcosis in a child with leukemia in remission.

Authors:  A D Lascari; J M Pearce; H Swanson
Journal:  South Med J       Date:  1997-12       Impact factor: 0.954

5.  Epidemiology of cryptococcal infection in hospitalized children.

Authors:  Neha S Joshi; Brian T Fisher; Priya A Prasad; Theoklis E Zaoutis
Journal:  Pediatr Infect Dis J       Date:  2010-12       Impact factor: 2.129

6.  Cryptococcosis in nonhuman immunodeficiency virus-infected children.

Authors:  Kuan-Ying Huang; Yhu-Chering Huang; Iou-Jih Hung; Tzou-Yien Lin
Journal:  Pediatr Neurol       Date:  2010-04       Impact factor: 3.372

7.  Fungal brain abscesses in leukemia.

Authors:  Fani Athanassiadou; Athanassios Tragiannidis; Theodotis Papageorgiou; Aristea Velegraki
Journal:  Indian Pediatr       Date:  2006-11       Impact factor: 1.411

Review 8.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

9.  Cryptococcosis in children with AIDS.

Authors:  J Abadi; S Nachman; A B Kressel; L Pirofski
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

10.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

  10 in total
  1 in total

1.  Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Authors:  Sabine Mousset; Dieter Buchheidt; Werner Heinz; Markus Ruhnke; Oliver A Cornely; Gerlinde Egerer; William Krüger; Hartmut Link; Silke Neumann; Helmut Ostermann; Jens Panse; Olaf Penack; Christina Rieger; Martin Schmidt-Hieber; Gerda Silling; Thomas Südhoff; Andrew J Ullmann; Hans-Heinrich Wolf; Georg Maschmeyer; Angelika Böhme
Journal:  Ann Hematol       Date:  2013-09-12       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.